Prescription errors can have devastating consequences for people of any age. The wrong dosage or medication can have long-lasting consequences and, in some cases, can be fatal. A recent article shows how children may be at greater risk for prescription errors in some circumstances. Since some medication is produced at dosages that are too high for children, they have to be reduced. The process of creating a smaller dosage is another opportunity for prescribers and pharmacists to make mistakes and for miscommunications to occur.
In the case of a Maryland prescription error, a plaintiff must demonstrate that the defendant was negligent by failing to meet the relevant standard of care. An example of this might be a pharmacist’s failure to administer the prescribed dosage. In these cases, a plaintiff may be entitled to compensation for their injuries.
Article Reveals Life-Threatening Errors in Administration of Flecainide to Children
Flecainide, an oral antiarrythmic drug, can be prescribed to treat supraventricular tachycardia or atrial fibrillation. However, it is only available commercially in doses of 50 mg, 100 mg, and 150 mg, so when given to infants and small children, who require smaller doses, it has to be given in the form of a suspension. A recent article discusses how there have been life-threatening errors during the preparation of the suspension, resulting in serious overdoses.